Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.
Considerations for providing feedback to patients and families regarding clinical high-risk for psychosis status.
复制标题
向患者和家属提供有关精神病状态临床高风险的反馈的考虑因素。
DOI:
10.1016/j.schres.2022.01.059
复制
发表时间:
2022
影响因子:
4.5
通讯作者:
Woods,ScottW
中科院分区:
文献类型:
--
作者:
Schiffman,Jason;Horton,LeslieE;Landa,Yulia;Woods,ScottW
Early identification and intervention in the at-risk phase of psychosis offers promise towards facilitating positive clinical and functional outcomes (Woods et al., 2021). Recent years have seen rapid growth in this field, spurred in part by SAMHSA’s 2018 Community Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk for Psychosis Grant Program (CHR-P Program). There are now approximately 500 first-episode clinics and 100 psychosis risk clinics in the US alone. Further, this year the NIMH has funded international collaborations to establish clinical high-risk for psychosis research networks. As psychotic disorders and associated terms can be stigmatizing (eg, Lasalvia et al., 2021; Mesholam-Gately et al., 2021), and the concept of “risk” is often misunderstood (eg, Stern & Fineberg, 2012), many of these programs are grappling with the questions about if and how to implement feedback about identified risk for psychosis. With a lack of established clinical best-practices for this process, clinicians are left ill-equipped to discuss this potentially confusing diagnosis and topic with patients and families. Without a thoughtful approach, inappropriate communication from clinicians may adversely impact patients, and lead to self-stigma, discouragement, hopelessness, and avoidance of treatment. Conversely, effective risk communication can potentially inspire hope and empowerment, as feedback is an essential part of fully informed care.In their paper, Woodberry et al.(2021) examined the emotional and stigma-related experiences of patients at high-risk for psychosis (CHR) before and after receiving formal clinical feedback about their CHR status. This is likely the first study to compare the impact of feedback for CHR on emotions or stigma-related experiences in this population pre and post, using both quantitative and qualitative methods. Among other findings, the authors reported less negative emotion in patients after being informed of their risk status, and no evidence to suggest that participants felt that they should keep their status private. Additionally, most participants had positive comments regarding the process of feedback, although there was a tendency for participants to feel negatively afterward about the possible impact of a CHR diagnosis on selfperceptions and others’ expectations about them. This work extends a nascent body of quantitative and qualitative research that suggests, among other findings, that stigma stems more from the experience of having CHR symptoms than from receiving a diagnosis (Yang et al., 2015); that CHR symptoms may result in stigma irrespective of whether a diagnosis is given (Anglin et al., 2014); that CHR-specific stigma is experienced as similar to that associated with non-psychotic diagnoses (Lee et al., 2016); that stigma is mitigated by knowledge about psychosis (Parrish et al., 2019); and that some patients feel a sense of relief in learning about their diagnosis from a professional (Uttinger et al., 2018).